District Sales Manager, West Coast (Life Sciences)

NanoString Technologies
Job Location
Field Based, preferably out of The Bay Area
San Francisco, CA
Competitive Comp Package -Uncapped Commissions

Benefits include but not limited to: ESPP, Stock Options, H/D/V Insurance, PTO, Matching 401K and more...

Job Description

The role of District Sales Manager requires a technically knowledgeable individual with outstanding interpersonal skills with experience managing Regional Account Managers in the sale of capital equipment and downstream consumables stream.  This position reports to the Vice President of Sales - Americas.


  • Manage a team of Regional Account Managers in a defined geographic area.
  • Deliver accurate regional revenue forecasts to Vice President of Sales.
  • Achieve quarterly and yearly revenue targets.
  • Recruit and retain sales professionals and provide effective coaching, mentoring and training to develop talent.
  • Ensure rigorous use of metrics to assess, coach and develop sales performance and enhance CRM funnel management over a three quarter window to ensure targets for instrumentation and large consumable orders can be met.
  • Identify, coach and assist with closing large regional sales opportunities.
  • Partner with the marketing organization to drive lead generation programs to support achievement of sales targets.
  • Maintain and assist with new hire orientation and training.
  • MS or BS in Molecular Biology, Biochemistry or related field.
  • A strong, technical understanding and familiarity with proteomics and gene expression technologies including qPCR, microarray analysis and Next Generation Sequencing.
  • 10 or more years of Regional Account Manager experience.
  • 5 or more years of leading or managing a team of Regional Account Managers.
  • An ability to travel 75% of the time.
  • A desire to participate in the growth and success of direct reports but also other members of the commercial team.
  • Exceptional administration skills including CRM and process documentation.
  • Exceptional communication skills, both oral and written.
  • Excellent time management and project management skills.
  • Ability and desire to participate in cross functional teams to launch new products or investigate customer issues.
How to Apply
About Our Organization

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

Organizations performing cancer research, biomarker validation and screening, and next-generation sequencing validation are rapidly adopting the nCounter® Analysis System. By providing simple, multiplexed digital profiling of single molecules, the NanoString platform represents a natural, digital downstream companion to next-generation sequencing and enables researchers to embark on studies that were previously inconceivable.

Leading researchers and institutions are finding that NanoString's nCounter system provides the ideal platform on which to validate their discoveries and translate them into clinically useful diagnostic assays. The nCounter system is uniquely positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues.

In addition to continuing to extend the applications for the nCounter system in the discovery, target validation and routine testing segments of the genomics research market, the company's goal is to become the platform of choice for diagnostic testing based on multiplexed gene signatures that can be offered in hospitals and pathology laboratories worldwide, following appropriate regulatory approvals. These two synergistic areas of business focus provide researchers with a seamless transition from discovery to diagnostics.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.